Studies of other valve diseases have focused on differences in prevalence, presentation and outcomes for surgical or transcatheter therapies. Defining sex-specific responses to valvular heart disease may improve disease recognition, define treatment strategies, and improve outcomes.

Editors

Editor-in-Chief
Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Authors
Rebecca T. Hahn, MD

Pamela S. Douglas, MD

Important Dates

Date of Release: April 11, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: April 10, 2023